About BSV Group
BSV Group is a company based in Mumbai (India) founded in 1971 was acquired by Mankind Pharma in July 2024. BSV Group has raised $18.15 million across 2 funding rounds from investors including Kotak Mahindra Bank, Mankind Pharma and Orbimed. BSV Group has completed 2 acquisitions, including Firstline and Genomicks. BSV Group offers products and services including Trinbelimab, Anti-Rho(D), Urinary Trypsin Inhibitor, and Recombinant FSH. BSV Group operates in a competitive market with competitors including Merck, Roivant Sciences, Gilead, Lilly and Vertex Pharmaceuticals, among others.
- Headquarter Mumbai, India
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Bharat Serums And Vaccines Limited
- Jurisdiction Mumbai, Maharashtra, India
-
Annual Revenue
$126.6 M (USD)2.67as on Mar 31, 2021
-
Net Profit
$13.47 M (USD)93.98as on Mar 31, 2021
-
EBITDA
$21.01 M (USD)51.86as on Mar 31, 2021
-
Total Equity Funding
$18.15 M (USD)
in 2 rounds
-
Latest Funding Round
$9.39 M (USD), Private Equity Round
Mar 31, 2010
-
Investors
Kotak Mahindra Bank
& 3 more
-
Employee Count
Not available
-
Investments & Acquisitions
Firstline
& 1 more
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BSV Group
BSV Group offers a comprehensive portfolio of products and services, including Trinbelimab, Anti-Rho(D), Urinary Trypsin Inhibitor, and Recombinant FSH.
Recombinant Anti Rh(o)-D Immunoglobin for treating Rh incompatibility.
World's first biotech antibody for Rh incompatibility management.
Inhibitor used in critical care for inflammatory conditions.
Assists in fertility treatments for reproductive health issues.
Funding Insights of BSV Group
BSV Group has successfully raised a total of $18.15M across 2 strategic funding rounds. The most recent funding activity was a Private Equity Round of $9.39 million completed in March 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in BSV Group
BSV Group has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Kotak Mahindra Bank, Mankind Pharma and Orbimed.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
|
Locked | Locked | Locked | |
|
Private equity firm focused on multiple sectors
|
Locked | Locked | Locked | |
|
Commercial banking services are offered to corporate and retail customers.
|
Locked | Locked | Locked |
Investor details for BSV Group
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BSV Group
BSV Group has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Firstline and Genomicks.
Investment portfolio details for BSV Group
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Medicines and diagnostic kits for fertility treatments are developed.
|
Locked | Locked | 2016 | Locked | |
|
Distributor of diversified drugs
|
Locked | Locked | 2007 | Locked |
Complete acquisition details for BSV Group
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - BSV Group
Detailed financials for BSV Group
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bsv Group Comparisons
Peer comparison for BSV Group
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BSV Group
BSV Group operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Merck, Roivant Sciences, Gilead, Lilly and Vertex Pharmaceuticals, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical products are manufactured and marketed worldwide.
|
|
| Locked | Locked | Locked |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
|
|
| Locked | Locked | Locked |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
|
|
| Locked | Locked | Locked |
Traditional pharmaceutical medicines are developed for multiple health fields.
|
|
| Locked | Locked | Locked |
Developer of drugs for the treatment of multiple disorders
|
|
| Locked | Locked | Locked |
Biopharmaceutical research and drug development are conducted globally by AbbVie.
|
Detailed competitors of BSV Group
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bsv Group
Complete news archive for BSV Group
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BSV Group
BSV Group was founded in 1971 and raised its 1st funding round 37 years after it was founded.
BSV Group is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Sanjiv Navangul is the current CEO of BSV Group.
BSV Group is a funded company, having raised a total of $18.15M across 2 funding rounds to date.
Annual revenue of BSV Group is $126.6M as on Mar 31, 2021.
BSV Group, established in 1971 and currently in Acquired stage, focuses on providing healthcare solutions, diversified pharmaceuticals, and drugs. Provider of drug research development services for pharmaceutical sector. Adapting to market demands with innovation and client-focused strategies. It continues to evolve, meeting industry challenges with strategic approaches.
BSV Group's top competitors include Merck, Roivant Sciences and AbbVie.
BSV Group offers Trinbelimab, Anti-Rho(D), Urinary Trypsin Inhibitor, and Recombinant FSH.
BSV Group has 4 investors. Key investors include Kotak Mahindra Bank, Mankind Pharma, Orbimed, and Advent International.